Symbol="INBX"
AssetType="Common Stock"
Name="InhibrxÂ Inc"
Description="Inhibrx, Inc., a clinical-stage biotechnology company, is focused on developing a line of new biological therapeutic candidates. The company is headquartered in La Jolla, California."
CIK="1739614"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="11025 N. TORREY PINES ROAD, SUITE 200, LA JOLLA, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1097807000"
EBITDA="-142652992"
PERatio="None"
PEGRatio="None"
BookValue="0.347"
DividendPerShare="0"
DividendYield="0"
EPS="-3.97"
RevenuePerShareTTM="0.031"
ProfitMargin="0"
OperatingMarginTTM="-112.4"
ReturnOnAssetsTTM="-0.433"
ReturnOnEquityTTM="-7.67"
RevenueTTM="1280000"
GrossProfitTTM="-107994000"
DilutedEPSTTM="-3.97"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.982"
AnalystTargetPrice="49"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="255.62"
PriceToBookRatio="35.04"
EVToRevenue="276.69"
EVToEBITDA="-11.74"
Beta="2.794"
num_52WeekHigh="34.72"
num_52WeekLow="12.6"
num_50DayMovingAverage="25.12"
num_200DayMovingAverage="25.37"
SharesOutstanding="43615700"
DividendDate="None"
ExDividendDate="None"
symbol="INBX"
open="25.18"
high="25.34"
low="22.69"
price="24.28"
volume="334781.00"
latest_trading_day="2023-07-24"
previous_close="25.17"
change="-0.89"
change_percent="-3.5360%"
aroon_positive_momentum_days="56"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="56"
Volume_recent_avg="356921"
Change_recent_avg="0.01"
Delta_recent_avg="1.52"
Variance_recent_avg="0.76"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="56"
Aroon_momentum_negative="44"
image_negative_thumbnail_id_1="1165"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0199.jpeg"
image_negative_thumbnail_id_2="1118"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_neutral_thumbnail_id_1="559"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_neutral_thumbnail_id_2="584"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_positive_thumbnail_id_1="603"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0105.jpeg"
image_positive_thumbnail_id_2="605"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0103.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
